Acadian Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $5K | Sell |
|
|||||
|
2023
Q4 | $38K | Sell |
|
|||||
|
2023
Q3 | $71K | Buy |
|
|||||
|
2023
Q2 | $145K | Sell |
|
|||||
|
2023
Q1 | $253K | Sell |
|
|||||
|
2022
Q4 | $578K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $114K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $43K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $123K | Sell |
|
|||||
|
2019
Q1 | $221K | Sell |
|
|||||
|
2018
Q4 | $535K | Sell |
|
|||||
|
2018
Q3 | $1.05M | Buy |
|
|||||
|
2018
Q2 | $687K | Buy |
|
|||||
|
2018
Q1 | $204K | Buy |
|